| abstract |
The present invention relates to compounds of general formula I: B— (CH——R 1 ) —C (═X 2 ) —D, and pharmaceutically acceptable salts, including stereoisomers, and mammals. It relates to the use of these compounds for the treatment of glucose intolerance in animals, diabetes, hyperlipidemia, metabolic acidosis, diabetes mellitus, diabetic neuropathy and nephropathy and sequelae caused by diabetes mellitus. |